Godavari Drugs Limited (BSE: 530317)
Health Care · Pharmaceuticals · IN
Rs101.00
-3.81% today · +21.8% 1Y
Godavari Drugs Limited (BSE: 530317) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $7.95M.
Over the last twelve months the share price has gained 21.8%, trading between 69.70 and 135.25.
Tweenvest scores Godavari Drugs Limited across four factors: quality 52/100, value 26/100, growth 0/100. Its strongest factor is quality.
530317 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $7.95M
- Revenue (TTM)
- $11.73M
- P/E
- 20.08
- EPS
- 5.03
- Dividend yield
- —
- Beta (5Y)
- 0.50
- 52-week high
- Rs135.25
- 52-week low
- Rs69.70
- Avg volume (3M)
- —
- Shares outstanding
- 7.53M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,247.37 | -0.64% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $273.00 | +1.02% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $150.91 | -1.08% |
| Roche Holding AGSWX: ROP | $373.91B | CHF370.40 | -1.38% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £121.10 | -1.06% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.03 | -0.14% |
Figures last refreshed Aug 18, 2026.